Gapping up
In reaction to earnings/guidance:
- LTHM +20.9%, OTLY +12.9%, SMCI +9.9%, PAYC +7.5%, GNRC +7.2%, MRNA +7%, ODP +7%, SBUX +6.6%, GEL +6.6%, THRM +6.1%, AMD +6%, LITE +5.9%, EHTH +5.8%, REZI +5.8%, VREX +5.4%, ABNB +5.3%, MUSA +5%, OSH +5%, LFUS +5%, LNG +4.7%, WERN +4.2%, PUMP +4.2%, BHG +4.2%, BDC +4.2%, INSP +4%, DOOR +3.8%, MSTR +3.7%, ASTE +3.7%, EQNR +3.6%, REG +3.4%, AIZ +2.9%, MAR +2.9%, CZR +2.8%, MATX +2.8%, LSCC +2.7%, CRUS +2.6%, AIG +2.5%, EIX +2.5%, IONS +2.5%, OMI +2.4%, FUN +2.3%, CRTO +2.3%, ATEN +2.2%, INSW +2.2%, STWD +2%, SPR +2%, CVS +1.9%, ATI +1.9%, TT +1.8%, VMC +1.8%, VVNT +1.7%, EXR +1.5%, WTS +1.5%, BRKR +1.5%, ONTO +1.4%, IOSP +1.3% (also increases dividend), REGN +1.3%, CDW +1.2%, WTI +1%, STAG +1%, EMR +1%
Other news:
- BXC +9.7% (increases share repurchase authorization to $100 mln; enters into $60 mln accelerated repurchase agreement)
- LDI +6.3% (announces planned launch of all-digital mello HELOC)
- CMPX +4.7% (reports additional interim results from a Phase 2 study of CTX-009 in combination with paclitaxel in patients with biliary tract cancers)
- NOG +2.1% (increases dividend; increases share repurchase authorization to $150 mln)
- NOVA +1.8% (launches fixed discount offering for solar customers)
- NDAQ +1.4% (reports April metrics)
- CDE +1.3% (provides balance sheet and liquidity update)
Analyst comments:
- SMG +3.9% (upgraded to Overweight from Neutral at JP Morgan)
- MQ +1.2% (initiated with an Outperform at Credit Suisse)